Portola Pharmaceuticals

Portola Pharmaceuticals

Therapeutics for acute and chronic cardiovascular, and autoimmune and inflammatory diseases.

  • Edit
Get premium to view all results
DateInvestorsAmountRound
-investor

€0.0

round
investor investor investor investor investor investor

€0.0

round
investor investor

€0.0

round
investor investor investor investor investor investor investor investor investor investor investor

€0.0

round
investor investor investor investor investor investor investor investor investor

€0.0

round
investor investor

€0.0

round
investor investor

€0.0

round
N/A

€0.0

round
N/A

€0.0

round
N/A

€0.0

round
N/A

€0.0

round
N/A

€0.0

round
investor investor

€0.0

round
N/A

€0.0

round
*

$1.4b

Valuation: $1.4b

Acquisition
Total Funding000k

Financials

Estimates*

Get premium to view all results
Edit
Revenues, earnings & profits over time
EUR20152016201720182019
Revenues00000000000000000000
EBITDA00000000000000000000
Profit00000000000000000000
EV00000000000000000000
EV / revenue00.0x00.0x00.0x00.0x00.0x
EV / EBITDA00.0x00.0x00.0x00.0x00.0x
R&D budget00000000000000000000

Source: Company filings or news article

Notes (0)
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Book a Demo